NDP019: Fertility consultation and recommendation in cancer patients—a survey from NCCN guidelines® china editions
  • 2017-12-25,
  • 上傳者: TUA秘書處,
  •  0
盧致誠1 ,2 范文宙1
1奇美醫療財團法人柳營奇美醫院 外科部 泌尿外科
Fertility consultation and recommendation in cancer patients—a survey from NCCN Guidelines® China Editions
Chih-Cheng Lu1,2   Wen-Chou Fan1
1Division of Urology, Department of Surgery, Chi Mei Medical Center, Liouying
2Department of Management Information System, National Chung Cheng University, Chiayi
Although evolving techniques of cancer treatment and improving survival rate in cancer patients, fertility is still an important issue among Chinese-speaking region. This is a study to explore the latest recommendation for fertility consultation in cancer patients.
Materials and Methods:
From the NCCN Guidelines® on line available, we collected the clinical practice guidelines up to 2017. Fertility or pregnancy consultation of the cancer patients were the focused keywords for survey.     
There were at least 47 treatment guidelines by sites of malignancies in NCCN Guidelines® on line. A total eight clinical guidelines in China editions were collected before this abstract submission.  There were prostate cancer, T-cell lymphoma, primary cutaneous B-cell lymphoma (PCBCL), Hodgkin’s lymphoma, Hairy cell leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), B-cell lymphoma, and multiple myeloma. Prostate cancer and multiple myeloma were the two cancers without fertility recommendation. The other 6 treatment guidelines for fertility consultation were based on evidence category of 2A (lower-level evidence, but uniform NCCN consensus that the intervention is appropriate).
In the present survey, not all cancer patients under treatment are recommended for fertility based on NCCN Guidelines® China editions. Further long term survey is needed for patients’ fertility with medicine progress.
訪客如要回應,請先 登入
    資料夾 :
    發表時間 :
    2017-12-25 17:03:33
    觀看數 :
    發表人 :
    部門 :
    QR Code :